+1q: amplifying the bad genes in myeloma
artículo científico publicado en 2017
6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance
artículo científico publicado en 2006
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis
scientific article published on 01 January 2007
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing
scientific article published on 13 February 2019
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
scientific article published on June 2010
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
artículo científico publicado en 2011
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
artículo científico publicado en 2013
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.
artículo científico publicado en 2001
A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an Eastern Cooperative Oncology Group Study
scientific article published on 01 July 2004
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).
artículo científico publicado en 2002
A novel report of cig-FISH and cytogenetics in POEMS syndrome.
artículo científico publicado en 2008
A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
artículo científico publicado en 2017
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
artículo científico publicado en 2017
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
artículo científico publicado en 2005
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin
artículo científico publicado en 2012
A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma
scientific article published on 01 December 1995
A phase II trial of imatinib in patients with refractory/relapsed myeloma
artículo científico publicado en 2006
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma
artículo científico publicado en 2012
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy
artículo científico publicado en 2007
A practical review on carfilzomib in multiple myeloma
artículo científico publicado en 2016
A reappraisal of immunoglobulin variable gene primers and its impact on assessing clonal relationships between PB B cells and BM plasma cells in AL amyloidosis
artículo científico publicado en 2011
A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis
artículo científico publicado en 2020
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine
scientific article published on 01 April 1997
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
artículo científico publicado en 2005
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis
scientific article published on 14 April 2020
Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.
artículo científico publicado en 2015
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma
scientific article published on 01 September 1999
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
artículo científico publicado en 2006
Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma
artículo científico publicado en 2004
Acquired Fanconi's syndrome associated with monoclonal gammopathies
artículo científico publicado en 1999
Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation
scientific article published on 13 June 2017
Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma.
artículo científico publicado en 2009
Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis
artículo científico publicado en 2012
Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide
scientific article published on 12 December 2020
Acute hyperviscosity: syndromes and management
artículo científico publicado en 2018
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis
artículo científico publicado en 2011
Acute leukemia and cytogenetic abnormalities complicating melphalan treatment of primary systemic amyloidosis
scientific article published on 01 March 1990
Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation
artículo científico publicado en 2005
Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation.
artículo científico publicado en 2009
Advanced skeletal imaging redefines the management of plasma cell disorders
artículo científico publicado en 2015
Advances in the treatment of amyloidosis
artículo científico publicado en 2007
Advances in the treatment of hereditary transthyretin amyloidosis: A review
artículo científico publicado en 2019
Allaying and alleviating amyloid agony and anxiety.
artículo científico publicado en 2013
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
scientific article published on 01 June 2006
Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples
scientific article published on 01 September 2020
Amyloid goiter as a manifestation of primary systemic amyloidosis
artículo científico publicado en 2007
Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type
artículo científico publicado el 1 de febrero de 1992
Amyloidosis
artículo científico publicado en 2005
Amyloidosis
artículo científico publicado en 2009
Amyloidosis and POEMS syndrome
artículo científico publicado en 2010
Amyloidosis and Waldenström's macroglobulinemia
artículo científico publicado en 2004
Amyloidosis with IgM monoclonal gammopathies
⬇️
artículo científico publicado el 1 de abril de 2003
Amyloidosis.
artículo científico publicado en 1999
Amyloidosis: diagnosis and management
artículo científico publicado en 2005
Amyloidosis: pathogenesis and new therapeutic options.
artículo científico publicado en 2011
Amyloidosis: recognition, confirmation, prognosis, and therapy
scientific article published on 01 May 1999
An unusual neurological complication of light chain amyloidosis
scientific article published on 16 September 2009
Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma
artículo científico publicado en 2018
Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).
artículo científico publicado en 2004
Antibody based immunotherapy for multiple myeloma: it's about time
artículo científico publicado en 2015
Aplastic anemia due to tocainide
artículo científico publicado en 1986
Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial
artículo científico publicado en 2017
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature
artículo científico publicado en 2010
Attitudes about when and how to treat patients with AL amyloidosis: an international survey.
artículo científico
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy
scientific article published on 14 July 2008
Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis
scholarly article by M Hasib Sidiqi et al published March 2019 in Biology of Blood and Marrow Transplantation
Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75
artículo científico publicado en 2018
Autologous attack on amyloidosis
artículo científico publicado en 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma
artículo científico publicado en 2006
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia
artículo científico publicado en 2006
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy
artículo científico publicado en 2008
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
artículo científico publicado en 2010
Autologous stem cell transplant for multiple myeloma patients 70 years or older
artículo científico publicado en 2016
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative
artículo científico publicado en 2008
Autologous stem cell transplantation and IgM amyloidosis
artículo científico publicado en 2006
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents
artículo científico publicado en 2020
Autologous stem cell transplantation for primary systemic amyloidosis
artículo científico publicado en 2002
Autologous stem cell transplantation for relapsed and primary refractory myeloma
artículo científico publicado en 1999
Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency
artículo científico publicado en 2015
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.
artículo científico publicado en 2003
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis
artículo científico publicado en 2008
Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function
scientific article published on 08 April 2019
Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis
artículo científico publicado en 1987
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner
scientific article published on 23 September 2020
Baby, it's cold outside!
⬇️
artículo científico publicado el 21 de junio de 2012
Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes
artículo científico publicado en 2020
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia
artículo científico publicado en 2018
Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma.
artículo científico publicado en 2015
Beta 2-microglobulin predicts survival in primary systemic amyloidosis
artículo científico publicado en 1990
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
artículo científico publicado en 2016
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma
artículo científico publicado en 1999
Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients
artículo científico publicado en 2008
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis
artículo científico publicado en 2020
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)
scientific article published on 01 November 2000
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis
scientific article published on 01 July 2002
Bone marrow angiogenesis in multiple myeloma: effect of therapy
article
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma
artículo científico publicado en 1999
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis
scientific article published on 22 November 2019
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
scholarly article by M Hasib Sidiqi et al published 8 November 2018 in Blood Cancer Journal
Bortezomib-based combination regimens in myeloma: more is not necessarily better
artículo científico publicado en 2014
Burden of hereditary transthyretin amyloidosis on quality of life
scientific article published on 13 June 2019
Caring (Really) for Patients Who Use Alternative Therapies for Cancer
⬇️
artículo científico publicado el 1 de mayo de 2003
Caring for the terminally ill patient with hematologic malignancies
artículo científico publicado en 2009
Case vignettes and other brain teasers of monoclonal gammopathies
artículo científico publicado el 1 de enero de 2012
Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis
artículo científico publicado en 2011
Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma
artículo científico publicado en 2017
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma
scientific article published on 28 August 2020
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma.
artículo científico publicado en 2015
Characteristics of late transplant-associated thrombotic microangiopathy (TA-TMA) in patients who underwent allogeneic hematopoietic stem cell transplantation
artículo científico publicado en 2020
Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis
artículo científico publicado en 2019
Characterization and prognostic implication of delayed complete response in AL amyloidosis
scientific article published on 23 November 2020
Chemoprevention for smoldering multiple myeloma: not ready for prime time
⬇️
artículo científico publicado el 7 de mayo de 2013
Chromosomal abnormalities in systemic amyloidosis
article
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
artículo científico publicado en 2003
Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis
artículo científico publicado en 2002
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma
artículo científico publicado en 2005
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry
artículo científico publicado en 2016
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
artículo científico publicado en 2010
Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow
artículo científico publicado en 1991
Clinical Course and Prognosis of Non-Secretory Multiple Myeloma
artículo científico publicado en 2015
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies
artículo científico publicado en 2016
Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both
artículo científico publicado en 2015
Clinical characteristics and outcomes in biclonal gammopathies
artículo científico publicado en 2016
Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study.
artículo científico publicado en 2018
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities
artículo científico publicado en 2020
Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy
artículo científico publicado en 2016
Clinical course and prognosis of non-secretory multiple myeloma
artículo científico publicado en 2015
Clinical course of patients with relapsed multiple myeloma
artículo científico publicado en 2004
Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics
artículo científico publicado en 2014
Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma
⬇️
artículo científico publicado en 2010
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney
artículo científico publicado en 2011
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis
scientific article published on 05 March 2019
Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma
artículo científico publicado en 2010
Clinical implication of centrosome amplification in plasma cell neoplasm
artículo científico publicado en 2005
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy
artículo científico publicado en 2005
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
artículo científico publicado en 2009
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
artículo científico publicado en 2017
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia
artículo científico publicado en 2017
Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma
artículo científico publicado en 1999
Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma
scientific article published on 17 February 2017
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.
artículo científico publicado en 2009
Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney Biopsies
scientific article published on 13 March 2012
Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor
artículo científico publicado en 2001
Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis
artículo científico publicado en 2013
Cold agglutinin disease
artículo científico publicado en 2006
Cold agglutinin disease and cryoglobulinemia
artículo científico publicado en 2005
Cold hemolytic syndrome
artículo científico publicado en 2006
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment
scientific article published on 06 October 2020
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
artículo científico publicado en 2005
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial
artículo científico publicado en 2005
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
artículo científico publicado en 2002
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.
artículo científico publicado en 2018
Comparative analysis of staging systems in AL amyloidosis
scientific article published on 23 January 2019
Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma
artículo científico publicado en 2008
Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis
⬇️
artículo científico publicado el 1 de julio de 1991
Conflicts of interest, authorship, and disclosures in industry-related scientific publications
artículo científico publicado en 2010
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
artículo científico
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.
artículo científico publicado en 2011
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.
artículo científico publicado en 2013
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.
artículo científico publicado en 2015
Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis
artículo científico publicado en 2020
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
artículo científico publicado en 2019
Correction: Waldenström macroglobulinemia treatment algorithm 2018.
artículo científico publicado en 2019
Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma
artículo científico publicado en 2010
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients
artículo científico publicado en 2020
Corrigendum to “Quantitative analysis of clonal bone marrow CD19+ B cells: Use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis” [Clin. Immunol. 120 (2006) 106–120]
scholarly article published in Clinical Immunology
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization
artículo científico publicado en 2012
Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma
artículo científico publicado en 2014
Critiquing cryos
artículo científico publicado en 2008
Current Trends in Diagnosis and Management of Cardiac Amyloidosis
⬇️
artículo científico publicado el 1 de febrero de 2013
Current and Emerging Treatments for Waldenström Macroglobulinemia
scientific article published on 18 August 2020
Current role of high dose chemotherapy in the management of multiple myeloma
artículo científico publicado en 2018
Current status of stem cell mobilization
artículo científico publicado en 2010
Current status of stem cell transplantation for multiple myeloma
artículo científico publicado en 2005
Current therapy for multiple myeloma
artículo científico publicado en 2002
Current therapy of myeloma induced renal failure
artículo científico publicado en 2008
Current treatment options for Waldenström macroglobulinemia
artículo científico publicado en 2008
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.
artículo científico publicado en 2016
Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple Myeloma
artículo científico publicado en 2006
Cytogenetic Abnormalities Correlate with the Plasma Cell Labeling Index and Extent of Bone Marrow Involvement in Myeloma
article
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy
artículo científico publicado en 2019
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response
artículo científico publicado en 2020
Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement
artículo científico publicado en 2020
Daratumumab for the treatment of AL amyloidosis
artículo científico publicado en 2018
Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
artículo científico publicado en 2018
Death during coronary angiography in a woman with cardiac amyloidosis
scientific article published on 01 June 2006
Deciding on the therapy of multiple myeloma using genetic risk stratification
⬇️
artículo científico publicado el 24 de enero de 2011
Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
artículo científico publicado en 2018
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
artículo científico publicado en 2005
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma
scientific article published on 21 October 2019
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma
artículo científico publicado en 2000
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression
article
Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis
artículo científico
Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis
artículo científico publicado en 2007
Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria
artículo científico publicado en 2018
Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria
scientific article published on 01 January 2019
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis
artículo científico publicado en 2020
Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis
⬇️
artículo científico publicado el 1 de febrero de 1998
Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma
scientific article published on 01 March 1995
Developing a clinical trial unit to advance research in an academic institution
artículo científico
Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma
artículo científico publicado en 2019
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia
artículo científico
Diagnosing primary amyloidosis
artículo científico publicado en 2002
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.
artículo científico publicado en 2017
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
artículo científico publicado en 2010
Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer
artículo científico publicado en 2017
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
scientific article published on 05 December 2019
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
artículo científico publicado en 2015
Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients
artículo científico publicado en 1992
Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant
artículo científico publicado en 2020
Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography
artículo científico publicado en 2004
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?
article by Eli Muchtar et al published 12 March 2018 in Amyloid
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs
artículo científico publicado en 2010
Does stem cell transplantation have a role in the management of multiple myeloma, 2009?
artículo científico publicado en 2009
Domino liver transplantation as a cause of acquired familial amyloid polyneuropathy
Doppler characterization of left ventricular diastolic function in cardiac amyloidosis
artículo científico publicado en 1989
Early Data on Long-Term Efficacy and Safety of Inotersen in Patients With Hereditary Transthyretin Amyloidosis: A 2-Year Update From the Open-Label Extension of the NEURO-TTR Trial
artículo científico publicado en 2020
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma
artículo científico publicado en 1999
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis
artículo científico publicado en 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
artículo científico publicado en 2001
Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.
artículo científico publicado en 2011
Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents
artículo científico publicado en 2016
Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenstrom's macroglobulinemia
artículo científico publicado en 2005
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.
artículo científico publicado en 2011
Effect of complete response on outcome following autologous stem cell transplantation for myeloma
scientific article published on 01 November 2000
Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response
artículo científico publicado en 2007
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia
⬇️
artículo científico publicado el 1 de noviembre de 2001
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.
artículo científico publicado en 2003
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.
artículo científico publicado en 2004
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma
artículo científico publicado en 2017
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials
artículo científico publicado en 2017
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma
artículo científico publicado en 2011
Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma
artículo científico publicado en 2011
Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement
artículo científico publicado en 2005
Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation
artículo científico publicado en 2017
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation
artículo científico publicado en 2017
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival
artículo científico publicado en 2001
Eliminating the complete response penalty from myeloma response assessment
artículo científico publicado en 2008
Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma
artículo científico
Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells
artículo científico publicado en 2020
Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial
artículo científico publicado en 1995
Erratum: International uniform response criteria for multiple myeloma
scholarly article published in Leukemia
Erratum: International uniform response criteria for multiple myeloma
article
Erratum: Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT
scholarly article published in Bone Marrow Transplantation
Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis
scholarly article published in Leukemia
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.
artículo científico publicado en 2011
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation
scientific article published on 13 July 2012
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie
artículo científico publicado en 2010
Evolution of Hematopoietic Cell Transplantation for Immunoglobulin Light Chain Amyloidosis
artículo científico
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma
artículo científico publicado en 2016
Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients
artículo científico publicado en 2005
Exhausted and outnumbered: CD4+ T cells in the myeloma battlefield
artículo científico publicado en 2020
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
scientific article published on 06 January 2020
Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry
artículo científico publicado en 2013
External beam radiation therapy for amyloidosis of the urinary bladder
artículo científico publicado en 2017
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma
artículo científico publicado en 2009
Factors influencing platelet recovery after blood cell transplantation in multiple myeloma
⬇️
artículo científico publicado el 1 de septiembre de 1997
Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period
artículo científico publicado el 1 de mayo de 1992
Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis
artículo científico publicado en 2001
Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: a report and review of growth factor-induced pulmonary toxicity
artículo científico publicado en 2000
Fever of unknown origin caused by multiple myeloma: a report of 9 cases
artículo científico publicado en 2002
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis
scientific article published on 11 July 2019
Finishing off fibrils
artículo científico publicado en 2009
First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis
artículo científico publicado en 2016
First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis
First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis.
artículo científico publicado en 2016
First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction
artículo científico publicado en 2016
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis
scientific article published on 01 October 2000
Fitting mSMART Into the Current Clinical Management of Waldenström Macroglobulinemia-Reply
artículo científico publicado en 2018
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.
artículo científico publicado en 2006
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system
artículo científico publicado en 2005
Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis
scientific article published on 07 October 2014
Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis
article
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma
artículo científico publicado en 2006
Genetic aberrations and survival in plasma cell leukemia
artículo científico publicado en 2008
Genetic variants in DNA repair pathways are not associated with disease progression among multiple myeloma patients
artículo científico publicado en 2013
Genomic abnormalities in monoclonal gammopathy of undetermined significance
scientific article published on 01 August 2002
Genotype, echocardiography, and survival in familial transthyretin amyloidosis.
artículo científico publicado en 2013
Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis
artículo científico publicado en 2007
Glycosylation of Immunoglobulin Light Chains is Highly Prevalent in Cold Agglutinin Disease
scientific article published on 01 May 2020
Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits
artículo científico
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis
artículo científico publicado en 2017
Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma
scientific article published on 29 September 2011
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients
scientific article published on 29 October 2019
Hemorrhagic cystitis complicating bone marrow transplantation
artículo científico publicado el 1 de febrero de 1992
Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients
artículo científico publicado en 1988
Herbs for hematology
artículo científico publicado en 2010
Hereditary ATTR amyloidosis: a single-institution experience with 266 patients
artículo científico
Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges
artículo científico publicado en 2017
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial
artículo científico publicado en 2018
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis
artículo científico publicado en 2001
High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia
artículo científico publicado en 2017
High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis
scientific article published on 08 January 2014
High-Dose Chemotherapy with Autotransplantation in AL Amyloidosis: A Flawed Meta-analysis
artículo científico publicado en 2009
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
scientific article published on 01 January 2008
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
artículo científico publicado en 2006
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement
artículo científico publicado en 2011
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy
artículo científico publicado en 2004
High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges
artículo científico publicado en 2016
How I treat cold agglutinin hemolytic anemia
artículo científico publicado en 2019
How I treat cryoglobulinemia.
artículo científico publicado en 2016
How we manage autologous stem cell transplantation for patients with multiple myeloma
artículo científico publicado en 2014
Hyperviscosity syndrome.
artículo científico publicado en 1995
Hyposplenism in primary systemic amyloidosis
artículo científico publicado en 1983
I don't know how to treat amyloidosis
artículo científico publicado en 2010
IAP antagonists induce anti-tumor immunity in multiple myeloma.
artículo científico publicado en 2016
IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma
artículo científico publicado en 2002
IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia
artículo científico publicado en 2012
Ibrutinib for the treatment of Waldenström macroglobulinemia
artículo científico
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
scientific article published on 29 August 2019
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia
artículo científico publicado en 2009
Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.
artículo científico publicado en 2006
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival
artículo científico publicado en 2009
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features
scientific article published on 28 November 2019
IgM Amyloidosis: Clinical Features in Therapeutic Outcomes
⬇️
artículo científico publicado el 1 de febrero de 2011
IgM myeloma: A multicenter retrospective study of 134 patients
artículo científico publicado en 2017
Immunoglobulin D amyloidosis: a distinct entity
artículo científico publicado en 2011
Immunoglobulin Light Chain Amyloidosis: 2020 Update on Diagnosis, Prognosis, and Treatment
artículo científico publicado en 2020
Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy
artículo científico publicado en 2016
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
artículo científico publicado en 2008
Immunoglobulin free light chains and solitary plasmacytoma of bone
artículo científico publicado en 2006
Immunoglobulin light chain amyloidosis
artículo científico publicado en 2013
Immunoglobulin light chain amyloidosis and the kidney
artículo científico publicado en 2002
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.
artículo científico publicado en 2018
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias
scientific article published on 02 September 2014
Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk‐stratification, and management
⬇️
artículo científico publicado el 1 de febrero de 2011
Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment
⬇️
artículo científico publicado el 1 de mayo de 2013
Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment
artículo científico publicado en 2014
Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment
artículo científico publicado en 2016
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment
scholarly article by Morie A Gertz et al published September 2018 in American Journal of Hematology
Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).
artículo científico publicado en 2002
Immunoglobulin light-chain amyloidosis: growing recognition, new approaches to therapy, active clinical trials
artículo científico publicado el 1 de febrero de 2012
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
artículo científico publicado en 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
artículo científico publicado en 2016
Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia
scientific article published on 31 December 2019
Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics
artículo científico publicado en 2017
Impact of acquired del(17p) in multiple myeloma
artículo científico publicado en 2019
Impact of additional cytoreduction following autologous SCT in multiple myeloma.
scientific article published on 16 June 2008
Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma
scientific article published on 19 March 2007
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis
scientific article published on 23 July 2019
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma
artículo científico publicado en 2015
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma
artículo científico publicado en 2009
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.
artículo científico publicado en 2018
Impact of early relapse after auto-SCT for multiple myeloma.
artículo científico publicado en 2008
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).
artículo científico publicado en 2017
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
artículo científico publicado en 2007
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis
artículo científico publicado en 2020
Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma
artículo científico publicado en 2016
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
artículo científico publicado en 2008
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma
scientific article published on 20 February 2019
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis
artículo científico publicado en 2017
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone
artículo científico publicado en 2009
Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity
scientific article published on 30 December 2019
Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma
artículo científico publicado en 2020
Implications of continued response after autologous stem cell transplantation for multiple myeloma
artículo científico publicado en 2013
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma
artículo científico publicado en 2020
Importance of FISH genetics in light chain amyloidosis
artículo científico publicado en 2017
Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma
artículo científico publicado en 2013
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study
artículo científico publicado en 2015
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
artículo científico publicado en 2017
Improved survival in multiple myeloma and the impact of novel therapies
artículo científico publicado en 2007
Improvement in Gastrointestinal Symptoms From Light Chain Amyloidosis After Adalimumab Therapy
scientific article published on 01 July 2019
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
artículo científico publicado en 2015
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains
artículo científico publicado en 2008
Improving strategies for the diagnosis of cardiac amyloidosis
artículo científico
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
scientific article published on 23 July 2015
In vivo and in silico studies on single versus multiple transplants for multiple myeloma
artículo científico publicado en 2007
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989
⬇️
artículo científico publicado el 1 de abril de 1992
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
artículo científico publicado en 2011
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation
artículo científico publicado en 2013
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients
scientific article published on 07 April 2020
Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis
artículo científico publicado en 2018
Individualizing cancer therapy
artículo científico publicado en 2010
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component
artículo científico publicado en 2009
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation
artículo científico publicado en 2016
Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality
artículo científico publicado en 1991
Initial immunoglobulin M ?flare? after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia
scientific article published on 01 December 2004
Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response
artículo científico publicado en 2004
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
artículo científico publicado en 2018
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis
scientific article published on 03 July 2019
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
scientific article published on 18 December 2019
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
artículo científico publicado en 2008
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
scientific article published on 25 June 2009
International uniform response criteria for multiple myeloma.
artículo científico publicado en 2006
Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
artículo científico publicado en 2016
Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis
artículo científico publicado en 2009
Intracardiac thrombosis and embolism in patients with cardiac amyloidosis
scientific article published on 05 November 2007
Is antisense nonsense?
artículo científico publicado en 2009
Jaw claudication in primary systemic amyloidosis
artículo científico publicado en 1986
Joint Pain and Proteinuria
scientific article published on 05 September 2019
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation
artículo científico publicado en 2020
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
artículo científico publicado en 2020
Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders
scientific article published on 30 May 2018
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis
artículo científico publicado en 2015
Late‐onset noninfectious pulmonary complications after allogeneic bone marrow transplantation
⬇️
artículo científico publicado el 1 de marzo de 1998
Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques
artículo científico publicado en 2004
Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction
artículo científico publicado en 2014
Left ventricular device implantation for advanced cardiac amyloidosis
artículo científico publicado en 2013
Lenalidomide - the new melphalan?
artículo científico publicado en 2016
Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
artículo científico publicado en 2009
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma
artículo científico publicado en 2010
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial
artículo científico publicado en 2011
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
artículo científico publicado en 2012
Life beyond bortezomib: increasing treatment options in refractory myeloma
artículo científico publicado en 2016
Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma
scientific article published on 01 September 2000
Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation
artículo científico publicado en 2018
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
artículo científico publicado en 2017
Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement
artículo científico publicado en 2005
Localized AL amyloidosis of the colon: an unrecognized entity
artículo científico publicado en 2003
Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience
artículo científico publicado en 2016
Long-term Outcomes of Sequential Hematopoietic Stem Cell Transplantation and Kidney Transplantation: Single-center Experience
artículo científico publicado en 2020
Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy
artículo científico publicado en 2014
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years
artículo científico publicado en 2008
Long-term outcome of autologous stem cell transplantation in light chain deposition disease
artículo científico publicado en 2008
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience
artículo científico publicado en 2016
Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT
artículo científico publicado en 2013
Long-term outcome of renal transplantation in light-chain deposition disease
artículo científico publicado en 2004
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
artículo científico publicado en 2013
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience
artículo científico publicado en 2012
Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis
artículo científico publicado en 2020
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation
artículo científico publicado en 2011
Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma.
artículo científico publicado en 2013
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma
artículo científico publicado en 2007
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma
artículo científico publicado en 2010
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia
artículo científico publicado en 2014
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis
artículo científico publicado en 2008
Long-term survival (10 years or more) in 30 patients with primary amyloidosis
scientific article published on 01 February 1999
Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003.
artículo científico publicado en 2008
Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms.
artículo científico publicado en 2013
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization
artículo científico publicado en 2010
Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia
artículo científico publicado en 2003
Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations
artículo científico publicado en 2016
Lymphoplasmacytic lymphoma: What we need to know
artículo científico publicado en 2015
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.
artículo científico publicado en 2017
Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis
artículo científico publicado en 2019
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies
artículo científico publicado en 2011
Making the Case to Study the Volume-Outcome Relationship in Hematologic Cancers
artículo científico
Management of cold haemolytic syndrome
artículo científico publicado en 2007
Management of induction failures in newly diagnosed transplant-eligible multiple myeloma
artículo científico publicado en 2019
Management of macroglobulinaemia
scientific article published on 09 May 2017
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines
scientific article published on December 2009
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.
artículo científico
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
artículo científico publicado en 2017
Managing light chain deposition disease
article published in 2011
Managing monoclonal gammopathy-associated neuropathy
artículo científico publicado en 2006
Managing myeloma kidney
scientific article published on 01 December 2005
Managing myeloma of the kidney
artículo científico publicado en 2007
Managing plasma cell leukemia
artículo científico publicado en 2007
Managing tumor lysis syndrome in 2010.
artículo científico publicado en 2010
Mayo Clinic Experience With Allogeneic and Syngeneic Bone Marrow Transplantation, 1982 Through 1990
⬇️
artículo científico publicado el 1 de febrero de 1992
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma
artículo científico publicado en 2006
Measurement of murine serum amyloid P component by rate nephelometry
⬇️
artículo científico publicado el 27 de abril de 1984
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
artículo científico publicado en 2011
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma
artículo científico publicado en 2020
Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation
article
MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts.
artículo científico publicado en 2011
Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling
article
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis
artículo científico publicado en 2019
Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation
artículo científico publicado en 1997
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).
artículo científico publicado en 2004
Multicentre versus single centre approach to rare diseases: The model of systemic light chain amyloidosis
article
Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation
Multiple Myeloma in the Time of COVID-19
scientific article published on 17 April 2020
Multiple myeloma - a cure within reach
artículo científico publicado en 2018
Multiple myeloma after kidney transplantation
artículo científico publicado en 2014
Multiple myeloma and kidney transplantation: the beginning of a new era
artículo científico publicado en 2019
Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases
artículo científico publicado en 1998
Multiple myeloma associated with diffuse osteosclerotic bone lesions: A clinical entity distinct from osteosclerotic myeloma (POEMS syndrome)
⬇️
artículo científico publicado el 1 de diciembre de 1997
Multiple myeloma: biology, standard therapy, and transplant therapy
artículo científico publicado en 2009
Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement
artículo científico publicado en 2005
Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report
artículo científico publicado en 2000
Myeloma and the newly diagnosed patient: a focus on treatment and management
artículo científico publicado en 2002
Myelomatous Involvement of the Central Nervous System
artículo científico publicado en 2016
Myopathy in primary systemic amyloidosis
artículo científico publicado en 1996
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma
artículo científico publicado en 2016
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System
artículo científico publicado en 2016
Natural history and therapy of 66 patients with mixed cryoglobulinemia
artículo científico publicado en 2006
Natural history of amyloidosis isolated to fat and bone marrow aspirate
artículo científico publicado en 2016
Natural history of multiple myeloma with de novo del(17p)
scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal
Natural history of t(11;14) multiple myeloma
artículo científico publicado en 2017
Natural history of thromboembolism in AL amyloidosis
artículo científico publicado en 2006
Nephelometric measurement of human serum amyloid P component (SAP)
artículo científico publicado en 1983
Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy
artículo científico publicado el 1 de octubre de 1984
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes
artículo científico publicado en 2012
New developments in diagnosis, risk assessment and management in systemic amyloidosis
scientific article published on 02 November 2019
New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression
scientific article published on December 2008
Newer Therapies for Amyloid Cardiomyopathy
artículo científico publicado en 2016
Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis
artículo científico publicado en 2020
Non-transplant eligible multiple myeloma: deciphering optimal first line regimens
scientific article published on 24 January 2020
Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.
artículo científico publicado en 2016
Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis
artículo científico publicado en 2006
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma
artículo científico publicado en 2007
OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS.
artículo científico publicado en 2017
Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis
artículo científico publicado en 2005
Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
artículo científico publicado en 2016
Ocular Manifestations of Familial Transthyretin Amyloidosis
artículo científico publicado en 2017
Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease
artículo científico publicado en 2002
Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio
scientific article published on 26 September 2018
Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient
scientific article published on 01 March 2007
Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibody
artículo científico publicado en 2016
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders
artículo científico publicado en 2008
Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant
artículo científico publicado en 2014
Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation
artículo científico publicado en 2020
Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation
artículo científico publicado en 2017
Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved
artículo científico publicado en 2019
Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation
artículo científico
Outcomes of patients with POEMS syndrome treated initially with radiation
artículo científico publicado en 2013
Outcomes of patients with renal monoclonal immunoglobulin deposition disease
artículo científico publicado en 2016
Outcomes of primary refractory multiple myeloma and the impact of novel therapies
artículo científico publicado en 2015
Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone (VRd) as first-line therapy in Multiple Myeloma
scientific article published on 16 December 2020
Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma
artículo científico publicado en 2019
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis
artículo científico publicado en 2020
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome
scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal
Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition
artículo científico publicado en 2017
POEMS syndrome: definitions and long-term outcome
artículo científico publicado en 2002
Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93)
scientific article published on 01 December 1998
Panobinostat in multiple myeloma
artículo científico publicado en 2016
Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib
artículo científico publicado en 2020
Pathophysiology and treatment of cardiac amyloidosis
artículo científico publicado en 2014
Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation
artículo científico publicado en 2001
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma
scientific article published on 13 December 2018
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
artículo científico publicado en 1996
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome
artículo científico publicado en 2008
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature
artículo científico publicado en 2004
Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma
scientific article published on 30 July 2018
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy
artículo científico publicado en 2013
Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib
artículo científico publicado en 2015
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
artículo científico publicado en 2010
Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma
artículo científico publicado en 2017
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
artículo científico publicado en 2015
Phase II trial of alpha-tocopherol (vitamin E) in the treatment of primary systemic amyloidosis
artículo científico publicado en 1990
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis
artículo científico publicado en 1999
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis
artículo científico publicado en 1999
Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis
scientific article published on 01 October 1993
Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia
artículo científico publicado en 2010
Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group study
artículo científico publicado en 1995
Pitfalls in the diagnosis of primary amyloidosis
artículo científico publicado en 2010
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma
article published in 2018
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response
artículo científico publicado en 2018
Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation
artículo científico publicado en 2018
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma
artículo científico publicado en 1999
Ploidy status rarely changes in myeloma patients at disease progression.
artículo científico publicado en 2005
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).
artículo científico publicado en 2010
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma
artículo científico publicado en 2009
Pomalidomide and myeloma meningitis
artículo científico publicado en 2013
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease
artículo científico publicado en 2011
Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma
artículo científico publicado en 2017
Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial
artículo científico
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis
artículo científico publicado en 2003
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy.
artículo científico publicado en 2015
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review
artículo científico publicado en 2003
Potential new risks of lenalidomide
artículo científico publicado en 2014
Pre-Existing Melanoma and Hematological Malignancies, Prognosis and Timing to Solid Organ Transplantation: A Consensus Expert Opinion Statement
scientific article published on 25 September 2020
Pre-Transplant Solid Organ Malignancy and Organ Transplant Candidacy: A Consensus Expert Opinion Statement
scientific article published on 24 September 2020
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
artículo científico publicado en 2010
Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratification
artículo científico publicado en 2013
Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study
artículo científico publicado en 2008
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma
artículo científico publicado en 2015
Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis
artículo científico publicado en 2017
Predictors of short-term survival in Waldenström Macroglobulinemia
artículo científico publicado en 2020
Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia
scientific article published on 02 October 2018
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience
artículo científico publicado en 2017
Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis
artículo científico publicado en 2017
Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients
artículo científico publicado en 2003
Primary amyloidosis (AL) in families
artículo científico publicado en 1986
Primary localized amyloidosis of the bladder: experience with dimethyl sulfoxide therapy
artículo científico publicado en 2002
Primary systemic amyloidosis
artículo científico publicado en 2002
Primary systemic amyloidosis in patients with Waldenström macroglobulinemia
artículo científico publicado en 2018
Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica
artículo científico publicado en 1994
Primary systemic amyloidosis presenting with asymmetric multiple mononeuropathies
artículo científico publicado en 2010
Primary systemic amyloidosis with delayed progression to multiple myeloma
artículo científico publicado en 1998
Primary systemic amyloidosis--a diagnostic primer
artículo científico publicado en 1989
Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine
artículo científico publicado en 1985
Primary systemic amyloidosis: a cause of malabsorption syndrome
⬇️
artículo científico publicado el 1 de noviembre de 2001
Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia
scientific article published on 01 May 1993
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
artículo científico publicado en 1995
Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy
artículo científico publicado en 1998
Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation
artículo científico publicado en 2020
Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis
scientific article published on 02 February 2019
Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis
artículo científico publicado en 2018
Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined Significance
article
Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003)
⬇️
artículo científico publicado el 1 de abril de 2003
Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).
artículo científico publicado en 2001
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations
artículo científico publicado en 2006
Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
artículo científico publicado en 2017
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia
artículo científico publicado en 2006
Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis
artículo científico publicado en 2019
Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis
artículo científico publicado en 2018
Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance
scientific article published on 30 January 2018
Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation
artículo científico publicado en 2020
Prognostic value of angiogenesis in solitary bone plasmacytoma
artículo científico publicado en 2002
Prognostic value of bone marrow angiogenesis in multiple myeloma
artículo científico publicado en 2000
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
artículo científico publicado en 2004
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma
artículo científico publicado en 2006
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy
artículo científico publicado en 2019
Prognostic value of urinary protein in primary systemic amyloidosis (AL)
artículo científico publicado en 1990
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
artículo científico publicado en 2004
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease
artículo científico publicado en 2001
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis
artículo científico publicado en 1999
Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management
artículo científico publicado en 2020
Proteomic Analysis of Waldenstrom Macroglobulinemia
article
Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis
artículo científico publicado en 2001
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
artículo científico publicado en 2016
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.
artículo científico publicado en 2014
Quantification of clonal circulating plasma cells in relapsed multiple myeloma
artículo científico publicado en 2014
Quantitative analysis of clonal bone marrow CD19+ B cells: use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis
artículo científico publicado en 2006
Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis
artículo científico publicado en 2003
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib
artículo científico publicado en 2016
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method
scientific article published on 08 January 2019
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
artículo científico publicado en 2016
Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis
scientific article published on 16 January 2019
Recent advances in the diagnosis and management of cardiac amyloidosis
artículo científico publicado en 2014
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score
artículo científico publicado en 2011
Recognition of congestive heart failure due to senile cardiac amyloidosis
artículo científico publicado en 1989
Reducing neurotoxicity in the management of multiple myeloma
⬇️
artículo científico publicado el 18 de agosto de 2011
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis
artículo científico publicado en 2012
Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio
artículo científico publicado en 2020
Refractory and relapsing multiple myeloma treated by blood stem cell transplantation
scientific article published on 01 March 1995
Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy
artículo científico publicado en 2015
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse
artículo científico publicado en 2018
Relationship Between Depth of Response and Outcome in Multiple Myeloma
scientific article published on 01 November 2007
Relevant prognostic features of multiple myeloma and the new International Staging System
artículo científico publicado en 2007
Remission of disseminated cancer after systemic oncolytic virotherapy
artículo científico publicado en 2014
Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro
artículo científico publicado en 2004
Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis
artículo científico publicado en 2005
Reply
artículo científico publicado en 2017
Reply to Castillo et al.
artículo científico publicado en 2018
Reply to S. Girnius et al.
artículo científico publicado en 2013
Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myeloma
artículo científico publicado en 2010
Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop
artículo científico publicado en 2012
Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature
artículo científico publicado en 1986
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma
artículo científico publicado en 2003
Response rates and survival in primary systemic amyloidosis
artículo científico publicado en 1991
Response to rituximab in patients with type II cryoglobulinemia
artículo científico publicado en 2006
Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy
artículo científico publicado en 2011
Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
artículo científico publicado en 2017
Retroperitoneal involvement with light chain amyloidosis- case series and literature review
artículo científico publicado en 2020
Retrospective cohort study of 148 patients with polyclonal gammopathy
artículo científico publicado en 2001
Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion
artículo científico publicado en 1994
Review of 1027 patients with newly diagnosed multiple myeloma
artículo científico publicado en 2003
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma
scholarly article by Praful Ravi et al published 15 November 2018 in Blood Cancer Journal
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements
artículo científico publicado en 2012
Revisiting complete response in light chain amyloidosis
scientific article published on 26 November 2019
Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival
artículo científico publicado en 2017
Risk adapted post-transplant maintenance in multiple myeloma
artículo científico publicado en 2019
Risk adapted therapy for multiple myeloma: back to basics
artículo científico publicado en 2014
Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment
artículo científico publicado en 2015
Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.
artículo científico publicado en 2016
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.
artículo científico publicado en 2018
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate
artículo científico publicado en 2004
Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis
artículo científico publicado en 2010
SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization
artículo científico publicado en 2010
Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma
artículo científico publicado en 2018
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation
artículo científico publicado en 2018
Salvage autologous stem cell transplant is an effective regimen for relapsed multiple myeloma
⬇️
artículo científico publicado el 17 de abril de 2013
Second auto-SCT for treatment of relapsed multiple myeloma
artículo científico publicado en 2012
Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance
artículo científico publicado en 2016
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma
artículo científico publicado en 2003
Secondary systemic amyloidosis: response and survival in 64 patients
artículo científico publicado en 1991
Selecting Initial Therapy for Newly Diagnosed Waldenström Macroglobulinemia
artículo científico publicado en 2018
Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation
artículo científico publicado en 2017
Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?
artículo científico publicado en 1995
Serum M-spike and transplant outcome in patients with multiple myeloma
artículo científico publicado en 2007
Serum amyloid A protein and C-reactive protein in systemic amyloidosis
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis
artículo científico publicado en 2004
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein
scientific article published on 15 August 2018
Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia
scientific article published on 01 June 2008
Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome
artículo científico publicado en 2010
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
artículo científico publicado en 2010
Serum uric acid: novel prognostic factor in primary systemic amyloidosis
artículo científico publicado en 2008
Severity of Baseline Proteinuria Predicts Renal Response in Immunoglobulin Light Chain-Associated Amyloidosis after Autologous Stem Cell Transplantation
artículo científico publicado en 2007
Shining a warm light on cryoglobulinemia
artículo científico publicado en 2013
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma
artículo científico publicado en 2004
Smoldering multiple myeloma requiring treatment: time for a new definition?
artículo científico publicado en 2013
Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.
artículo científico publicado en 2015
Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses
artículo científico publicado en 2002
Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay
artículo científico publicado en 2018
Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis
artículo científico publicado en 2020
Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time
artículo científico publicado en 2018
Stem cell transplant for Waldenström macroglobulinemia: an underutilized technique
⬇️
artículo científico publicado el 29 de agosto de 2011
Stem cell transplant: an effective salvage therapy for multiple myeloma
⬇️
artículo científico publicado el 12 de junio de 2011
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis
artículo científico publicado en 2016
Stem cell transplantation for immunoglobulin light chain amyloidosis
artículo científico publicado en 2017
Stem cell transplantation for the management of primary systemic amyloidosis
artículo científico publicado en 2002
Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction
artículo científico publicado en 2010
Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis
artículo científico publicado en 2010
Substratification of patients with newly diagnosed standard-risk multiple myeloma
scientific article published on 15 February 2019
Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation
artículo científico publicado en 2001
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation
artículo científico publicado en 2005
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study
artículo científico publicado en 2004
Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis
scientific article published on 23 September 2019
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins
artículo científico publicado en 2003
Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis
artículo científico publicado en 2000
Synovial fluid analysis for diagnosis of amyloid arthropathy
Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients
artículo científico publicado en 2010
Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review
artículo científico publicado en 2020
Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome
artículo científico publicado en 2016
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma
artículo científico publicado en 2013
Systemic amyloidosis from A (AA) to T (ATTR): a review
scientific article published on 14 September 2020
Systemic immunoglobulin light chain amyloidosis
TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients
artículo científico publicado en 2020
Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis
artículo científico publicado en 2012
Ten-year survivors in AL amyloidosis: characteristics and treatment pattern
scientific article published on 12 July 2019
Testicular plasmacytoma: unique location or circumstantial presentation?
artículo científico publicado en 2018
Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma
scientific article published on 06 February 2019
Thalidomide as initial therapy for early-stage myeloma
artículo científico publicado en 2003
Thalidomide for previously untreated indolent or smoldering multiple myeloma
artículo científico publicado en 2001
Thalidomide in the treatment of relapsed multiple myeloma
scientific article published on 01 September 2000
The Classification and Typing of Amyloid Deposits
The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors
scientific article published on 16 July 2019
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
artículo científico publicado en 2006
The classification and typing of amyloid deposits
artículo científico publicado en 2004
The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance
artículo científico publicado en 2019
The colorful landscape of multiple myeloma
scientific article published on 27 February 2019
The current landscape of multiple myeloma treatment
artículo científico publicado en 2008
The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis
artículo científico publicado en 2013
The dilemma of jaw osteonecrosis in patients with multiple myeloma
artículo científico publicado en 2008
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma
artículo científico publicado en 2004
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma
artículo científico publicado en 2005
The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation
artículo científico publicado en 2015
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents.
artículo científico publicado en 2016
The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma
artículo científico publicado en 2019
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma
scientific article published on 29 July 2009
The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response
scientific article published on 30 January 2018
The importance of immunoparesis in multiple myeloma
artículo científico publicado en 2020
The plasma cell labeling index: a valuable tool in primary systemic amyloidosis
scientific article published on 01 August 1989
The premortem recognition of systemic senile amyloidosis with cardiac involvement
artículo científico publicado en 1996
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma
artículo científico publicado en 2016
The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma
artículo científico publicado en 2017
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment
artículo científico publicado en 2016
The role of bendamustine in the management of plasma cell myeloma
artículo científico publicado en 2014
The role of bisphosphonate therapy in the global management of multiple myeloma
⬇️
artículo científico publicado el 14 de marzo de 2011
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
scientific article published on 06 May 2020
The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myeloma
artículo científico publicado en 2008
The role of phosphatase and tensin homolog deleted on chromosome 10 and focal adhesion kinase in aggressive multiple myeloma
⬇️
artículo científico publicado el 31 de enero de 2012
The role of stem cell transplantation in Waldenstrom's macroglobulinemia
artículo científico publicado en 2016
The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry
scientific article published on 25 June 2019
The spectrum of monoclonal gammopathies affecting the kidney
scientific article published on 04 May 2012
The use of cell lines for the study of Waldenström's macroglobulinemia
scientific article published on 03 June 2008
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome
scientific article published on 31 August 2011
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
artículo científico publicado en 2017
Therapy for immunoglobulin light chain amyloidosis: the new and the old.
artículo científico publicado en 2004
Therapy of Transthyretin Cardiomyopathy
artículo científico publicado en 2019
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents
article
Thermal stability threshold for amyloid formation in light chain amyloidosis
artículo científico publicado en 2013
Thrombotic microangiopathy during peripheral blood stem cell mobilization
artículo científico publicado en 2009
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
artículo científico publicado en 2018
Transient acantholytic dermatosis associated with lymphomatous angioimmunoblastic lymphadenopathy.
artículo científico publicado en 1989
Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
artículo científico publicado en 2009
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis
artículo científico publicado en 2001
Transplantation for IgM amyloidosis and IgM myeloma
artículo científico publicado en 2009
Transplantation for amyloidosis
artículo científico publicado en 2007
Transplantation for multiple myeloma. Pertinent Questions
artículo científico publicado en 2003
Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).
artículo científico publicado en 2007
Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?
artículo científico publicado en 2016
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia
scientific article published on 15 October 2020
Treatment of Castleman's disease
artículo científico publicado en 2005
Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement
artículo científico
Treatment of POEMS syndrome
artículo científico publicado en 2004
Treatment of immunoglobulin light chain (primary or AL) amyloidosis.
artículo científico publicado en 2011
Treatment of immunoglobulin light chain amyloidosis
scientific article published on April 2009
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
artículo científico publicado en 2007
Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapy
artículo científico publicado el 1 de octubre de 2012
Treatment of refractory multiple myeloma and considerations for future therapy
artículo científico publicado en 1986
Treatment options for POEMS syndrome
artículo científico publicado en 2005
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis
artículo científico publicado en 2017
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus
artículo científico publicado en 2014
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia
artículo científico publicado en 2016
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
artículo científico publicado en 2003
Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006
⬇️
artículo científico publicado el 1 de junio de 2011
Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic
artículo científico
Trends and outcomes of modern staging of solitary plasmacytoma of bone
artículo científico publicado en 2012
Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.
artículo científico publicado en 2010
Trends in survival of patients with primary plasma cell leukemia: a population-based analysis
artículo científico publicado en 2014
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics
artículo científico publicado en 2012
Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis
artículo científico publicado en 2008
Troponin in hematologic oncology
artículo científico publicado en 2008
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications
artículo científico publicado en 2006
Two types of amyloidosis presenting in a single patient: a case series
artículo científico publicado en 2019
Two-dimensional acoustic pattern derived strain parameters closely correlate with one-dimensional tissue Doppler derived strain measurements
artículo científico publicado en 2005
Unravelling hypothyroidism in AL amyloidosis: Authors' reply.
artículo científico publicado en 2017
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia
artículo científico publicado en 2006
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia
artículo científico publicado en 2008
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia
artículo científico publicado en 2006
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases
artículo científico publicado en 2012
Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide
artículo científico publicado en 2020
Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma
artículo científico publicado en 2020
Using Novel Agents and Stem Cell Transplantation to Optimally Manage Immunoglobulin Light Chain Amyloidosis
artículo científico publicado en 2015
Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma
artículo científico publicado en 2018
Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosi
artículo científico publicado en 2011
Utility of gallium imaging of the kidneys in diagnosing primary amyloid nephrotic syndrome
artículo científico publicado en 1990
Utility of immunophenotyping of plasma cells in multiple myeloma
artículo científico publicado en 2015
Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma
artículo científico publicado en 2020
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
artículo científico publicado en 2015
Utility of serum free light chain ratio in response definition in patients with multiple myeloma
artículo científico publicado en 2020
Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain)
scientific article published on 01 April 1988
Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis
scientific article published on 01 June 1987
Utility of the immunoglobulin free light chain assay for plasma cell disorders 2015.
artículo científico publicado en 2015
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.
artículo científico publicado en 2019
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia
artículo científico publicado en 2020
V122I Transthyretin Cardiomyopathy: An Opportunity to Build Trust and Resolve Disparities
artículo científico publicado en 2020
Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin
scientific article published on 15 November 2018
Vascular abnormalities in primary amyloidosis
artículo científico publicado en 2007
Venetoclax for the treatment of multiple myeloma
scientific article published on 06 December 2018
Venetoclax for the treatment of translocation (11;14) AL amyloidosis
scientific article published on 11 May 2020
Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator
artículo científico publicado en 2002
Vinblastine-Loaded Platelets for Autoimmune Hemolytic Anemia
artículo científico publicado el 1 de septiembre de 1981
Waldenstrom's macroglobulinemia in the era of immunotherapy
artículo científico publicado en 2020
Waldenström Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management
⬇️
artículo científico publicado el 1 de mayo de 2012
Waldenström Macroglobulinemia: 2020 Update on Diagnosis, Risk Stratification, and Management
artículo científico publicado en 2020
Waldenström macroglobulinaemia.
artículo científico publicado en 2003
Waldenström macroglobulinaemia: the key questions.
artículo científico
Waldenström macroglobulinemia
scientific article published on 15 February 2007
Waldenström macroglobulinemia
artículo científico publicado en 2015
Waldenström macroglobulinemia treatment algorithm 2018.
artículo científico publicado en 2018
Waldenström macroglobulinemia.
artículo científico publicado en 2012
Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management
⬇️
artículo científico publicado el 1 de mayo de 2011
Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management
⬇️
artículo científico publicado el 20 de junio de 2013
Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management
artículo científico publicado en 2015
Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management
artículo científico publicado en 2017
Waldenström macroglobulinemia: 2018 update on diagnosis, risk stratification, and management
scientific article published on 17 October 2018
Waldenström macroglobulinemia: a review of therapy
artículo científico publicado en 2005
Waldenström macroglobulinemia: is newer really better?
⬇️
artículo científico publicado el 11 de noviembre de 2010
Waldenström macroglobulinemia: my way
⬇️
artículo científico publicado el 25 de agosto de 2012
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil
artículo científico publicado en 2000
Waldenström's macroglobulinemia
artículo científico publicado en 2000
Waldenström's macroglobulinemia: a review of therapy
artículo científico publicado en 2002
What do I need to know about immunoglobulin light chain (AL) amyloidosis?
artículo científico publicado en 2012
What is Waldenström macroglobulinemia?
⬇️
artículo científico publicado el 29 de julio de 2013
What is the correct philosophy for the treatment of multiple myeloma?
artículo científico publicado en 2007
What's new in Waldenström macroglobulinemia
⬇️
artículo científico publicado el 1 de octubre de 2010
When is myeloma, myeloma?
scientific article published on 01 August 2006
When to Suspect a Diagnosis of Amyloidosis
artículo científico publicado en 2020
When to recommend allogeneic transplant in multiple myeloma
artículo científico
Will we be able to afford a cure in multiple myeloma?
artículo científico publicado en 2017
Worldwide Perspectives of Amyloidosis
artículo científico publicado en 2020
Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents
artículo científico publicado en 1985
Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis
artículo científico publicado en 2014
You should see the other guy
⬇️
artículo científico publicado el 30 de septiembre de 2010